MedTrace Logo

SpotLight-19 Research & Development Study

NCT05198869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12500

Last updated 2022-01-20

No results posted yet for this study

Summary

In this study, we will use the SpotLight-19 device in patients presenting to a coronavirus disease (COVID-19) Assessment Centre for polymerase chain reaction (PCR) testing. Consenting patients will undergo a Spotlight-19 scan. We will link the scan to PCR results, age, vaccination status, and COVID-19 symptoms in order to calibrate the SpotLight-19 prediction algorithm of a state of COVID-19 infection.

Conditions

  • Screening

Interventions

DEVICE

Spectral scan

Consenting participants will have a SpotLight-19 scan

Sponsors & Collaborators

  • ISBRG Corp

    collaborator OTHER

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Rae Lake, MD · ISBRG Corp

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-29
Primary Completion
2022-04-30
Completion
2022-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198869 on ClinicalTrials.gov